Skip to main content
NIH funding notice RFA-MH-20-340

Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed)

Closed on January 31, 2020.

Posted
November 27, 2019
Close date
January 31, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $15,588,355 in first-year total cost, median $7,794,178.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-S (06)]2

Most frequent institutions

  1. UNIVERSITY OF MELBOURNE1
  2. YALE UNIVERSITY1
Competing awards under RFA-MH-20-340 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020ProNET: Psychosis-Risk Outcomes Network1U01MH124639-01BEARDEN, CARRIE EKANE, JOHN MWOODS, SCOTT WYALE UNIVERSITY, CT$10,861,093ZMH1
2020Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)1U01MH124631-01NELSON, CHRISTOPHER BARNABYUNIVERSITY OF MELBOURNE$4,727,262ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.